Evaluation of Natural Human Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu in Perth, Western Australia.

Trial Profile

Evaluation of Natural Human Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu in Perth, Western Australia.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2011

At a glance

  • Drugs Interferon alpha (Primary)
  • Indications Common cold; Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors Amarillo Biosciences
  • Most Recent Events

    • 09 Apr 2010 The final report of the results from this trial has been submitted to the State Health Research Advisory Council of the DOH, Western Austrlia, and have been published on the Amarillo Biosciences website according to an Amarillo Biosciences media release.
    • 16 Feb 2010 According to an Amarillo Biosciences media release, a substudy in older participants indicated a benefit in preventing influenza-like illness.
    • 05 Feb 2010 Status changed from active, no longer recruiting to completed, according to an Amarillo Biosciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top